La Jolla, CA, United States of America

Stacie S Canan-Koch



Average Co-Inventor Count = 4.0

ph-index = 3

Forward Citations = 48(Granted Patents)


Company Filing History:


Years Active: 2002-2008

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Stacie S Canan-Koch: Innovator in Cancer Therapeutics

Introduction

Stacie S Canan-Koch is a prominent inventor based in La Jolla, CA (US). She has made significant contributions to the field of cancer therapeutics, holding a total of 3 patents. Her work focuses on developing innovative compounds that can aid in the treatment of various medical conditions.

Latest Patents

Among her latest patents are the tricyclic inhibitors of poly(ADP-ribose) polymerases. These compounds are designed to act as poly(ADP-ribosyl)transferase (PARP) inhibitors, which are useful in treating cancers and alleviating the effects of stroke, head trauma, and neurodegenerative diseases. The compounds may be utilized in combination with cytotoxic agents and/or radiation, showcasing their potential as effective cancer therapeutics.

Career Highlights

Stacie has worked with notable companies such as Agouron Pharmaceuticals, Inc. and Cancer Research Campaign Technology Limited. Her experience in these organizations has allowed her to contribute to groundbreaking research and development in the pharmaceutical industry.

Collaborations

Throughout her career, Stacie has collaborated with esteemed colleagues, including Stephen Evan Webber and Jayashree Tikhe. These partnerships have further enhanced her research and innovation in the field.

Conclusion

Stacie S Canan-Koch is a trailblazer in the development of cancer therapeutics, with a focus on innovative compounds that hold promise for treating serious medical conditions. Her contributions to the field are invaluable and continue to impact the lives of many.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…